- Home
- PBT vs HUMA Comparison
PBT vs HUMA Comparison
Compare PBT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- HUMA
- Stock Information
- Founded
- PBT 1980
- HUMA 2004
- Country
- PBT United States
- HUMA United States
- Employees
- PBT N/A
- HUMA N/A
- Industry
- PBT Oil & Gas Production
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- PBT Energy
- HUMA Health Care
- Exchange
- PBT Nasdaq
- HUMA Nasdaq
- Market Cap
- PBT 562.6M
- HUMA 367.6M
- IPO Year
- PBT N/A
- HUMA N/A
- Fundamental
- Price
- PBT $12.61
- HUMA $2.25
- Analyst Decision
- PBT
- HUMA Strong Buy
- Analyst Count
- PBT 0
- HUMA 7
- Target Price
- PBT N/A
- HUMA $13.00
- AVG Volume (30 Days)
- PBT 307.0K
- HUMA 3.3M
- Earning Date
- PBT 01-01-0001
- HUMA 08-12-2025
- Dividend Yield
- PBT 4.32%
- HUMA N/A
- EPS Growth
- PBT N/A
- HUMA N/A
- EPS
- PBT 0.48
- HUMA N/A
- Revenue
- PBT $24,140,674.00
- HUMA $517,000.00
- Revenue This Year
- PBT N/A
- HUMA N/A
- Revenue Next Year
- PBT N/A
- HUMA $896.45
- P/E Ratio
- PBT $25.79
- HUMA N/A
- Revenue Growth
- PBT N/A
- HUMA N/A
- 52 Week Low
- PBT $8.01
- HUMA $1.15
- 52 Week High
- PBT $14.26
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- PBT 78.16
- HUMA 41.39
- Support Level
- PBT $11.78
- HUMA $2.09
- Resistance Level
- PBT $12.60
- HUMA $2.26
- Average True Range (ATR)
- PBT 0.30
- HUMA 0.13
- MACD
- PBT 0.04
- HUMA -0.06
- Stochastic Oscillator
- PBT 97.87
- HUMA 5.57
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.